+IVV-CSF Rev5-Specific Provider Responsibilities
---+IVV-CSF-AIA Annual Independent Assessments for Rev5
------+IVV-CSF-AIA Annual Independent Assessments for Rev5 – Class B
------+IVV-CSF-AIA Annual Independent Assessments for Rev5 – Class C
------+IVV-CSF-AIA Annual Independent Assessments for Rev5 – Class D
---+IVV-CSF-MCA Mandatory Control Assessment
---+IVV-CSF-ACF Assessment of Rev5 Controls with Findings
---+IVV-CSF-PCA Preferred Control Assessment
|
IVV-CSF Rev5-Specific Provider Responsibilities
These rules apply to providers for FedRAMP Rev5 Certifications. - Types: Rev5
- Paths: Program, Agency
- Classes: B, C, D
- Affects: Providers
1. Преглед
| Наименование |
Стандарт |
|
IVV-CSF-AIA Annual Independent Assessments for Rev5
|
Class BProviders with Rev5 Class B Certifications MUST include the following Rev5 Controls in a FedRAMP independent assessment at least once per year: Timeframe: 1 year Class CProviders with Rev5 Class C Certifications MUST include the following Rev5 Controls in a FedRAMP independent assessment at least once per year: Timeframe: 1 year Class DProviders with Rev5 Class D Certifications MUST include the following Rev5 Controls in a FedRAMP independent assessment at least once per year: Timeframe: 1 year Defined terms: FedRAMP Independent Assessment
|
|
IVV-CSF-MCA Mandatory Control Assessment
|
Providers MUST have all applicable Rev5 Controls included in FedRAMP independent assessments every 3 years but are not required to have all Rev5 Controls included in the same FedRAMP independent assessment. NoteTraditionally this has been done by reviewing a rotating selection of Rev5 Controls at each annual assessment, however this requirement is a ceiling and not a floor. See IVV-CSF-PCA (Preferred Control Assessment) for FedRAMP's recommended approach to Rev5 control assessments. Timeframe: 3 years Related rules: IVV-CSF-PCA Defined terms: FedRAMP Independent Assessment
|
|
IVV-CSF-ACF Assessment of Rev5 Controls with Findings
|
Providers MUST have Rev5 Controls with negative findings from the previous FedRAMP independent assessment included in the next FedRAMP independent assessment. Defined terms: FedRAMP Independent Assessment
|
|
IVV-CSF-PCA Preferred Control Assessment
|
Providers SHOULD include all applicable Rev5 Controls in each FedRAMP independent assessment. Defined terms: FedRAMP Independent Assessment
|
1.1 Препратки
1.2 Идентифицирани изисквания
1.3 Свързани регулации
2. Идентифицирани изисквания
Изисквания
| Източник |
Изискване |
3. Свързани регулации
Регулации
| Източник |
Регулация |
- FedRAMP Consolidated Rules -
EN: FedRAMP® Consolidated Rules of the Federal Risk and Authorization Management Program, U.S. General Services Administration (GSA), https://www.fedramp.gov/, from their machine-readable version (FedRAMP/rules). Works of the U.S. Government are not subject to copyright protection in the United States (17 U.S.C. § 105; GSA website policies); GSA dedicated its machine-readable FedRAMP content to the public domain worldwide (CC0 1.0). FedRAMP® is a registered trademark of GSA; GRCA is not affiliated with, nor endorsed by, GSA or FedRAMP. Divided into sections and converted into the GRCA format, the wording unchanged, linked to the NIST SP 800-53 controls they name. Only the version published by FedRAMP is authoritative.
DE: FedRAMP® Consolidated Rules des Federal Risk and Authorization Management Program, U.S. General Services Administration (GSA), https://www.fedramp.gov/, aus ihrer maschinenlesbaren Fassung (FedRAMP/rules). Werke der US-Regierung sind in den USA urheberrechtlich nicht geschützt (17 U.S.C. § 105; Website-Richtlinien der GSA); die GSA hat ihre maschinenlesbaren FedRAMP-Inhalte weltweit gemeinfrei gestellt (CC0 1.0). FedRAMP® ist eine eingetragene Marke der GSA; GRCA steht in keiner Verbindung zur GSA oder zu FedRAMP und wird von ihnen nicht unterstützt. In Abschnitte aufgeteilt und in das GRCA-Format umgewandelt, der Wortlaut unverändert, mit den genannten Controls aus NIST SP 800-53 verknüpft. Maßgeblich ist allein die von FedRAMP veröffentlichte Fassung.
|